Mizuho Securities Downgrades Anacor Pharmaceuticals (ANAC) to Neutral on Pending Takeover
Tweet Send to a Friend
Mizuho Securities downgraded Anacor Pharmaceuticals (NASDAQ: ANAC) from Outperform to Neutral with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
